Design, Synthesis, and Evaluation of New Anticancer Substances and Radiopharmaceuticals
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 21
Special Issue Editors
Interests: medicinal chemistry; organic synthesis; heterocycles; anticancer activity; antimicrobial activity; SAR
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; biomarkers; radiopharmaceuticals; radiomics; anticancer activity; in vitro/in vivo evaluation models; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The development of novel anticancer agents and radiopharmaceuticals remains a multidisciplinary field at the intersection of medicinal chemistry, molecular biology, pharmacology, and nuclear medicine. This research area focuses on the rational design, synthesis, and biological evaluation of new compounds with selective cytotoxicity against cancer cells. A growing emphasis is placed on targeting specific molecular pathways and tumor biomarkers to improve therapeutic efficacy and reduce their systemic toxicity. Radiopharmaceuticals, which combine biologically active molecules with radioactive isotopes, offer both diagnostic and therapeutic (theranostic) potential—enabling personalized treatment strategies and real-time monitoring of therapeutic outcomes. Advances in synthetic methodologies, structure–activity relationship (SAR) studies, and in vitro/in vivo evaluation models are accelerating the translation of promising candidates from bench to bedside. This topic invites contributions highlighting innovative approaches to the design and functional evaluation of small molecules, metal complexes, peptides, or nanoparticles with anticancer and/or radiopharmaceutical applications.
Prof. Dr. Monika Pitucha
Dr. Marta Rusek
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- synthesis
- anticancer activity
- radiopharamceuticals
- organic compounds
- medicinal chemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
